Lista de obras - Gregory L Beatty - Dominio Público Uruguay

A Pilot Study of Galunisertib Plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma

scientific article published on 02 December 2020

A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma

artículo científico publicado en 2013

Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer.

artículo científico publicado en 2008

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

artículo científico publicado en 2011

CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer

artículo científico

Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists.

artículo científico publicado en 2016

Chimeric antigen receptor T cells are vulnerable to immunosuppressive mechanisms present within the tumor microenvironment

artículo científico publicado en 2014

Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps

artículo científico publicado en 2016

Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers

artículo científico publicado en 2009

EMT and dissemination precede pancreatic tumor formation

artículo científico publicado en 2012

Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma.

artículo científico publicado en 2014

Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages

artículo científico publicado en 2015

Expanding Tumor Lymphocytic Infiltration as a Prognostic Tool to Patients with NSCLC Who Are Treated with Radiotherapy?

artículo científico publicado en 2016

First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies.

artículo científico publicado en 2017

Functio Laesa: Cancer Inflammation and Therapeutic Resistance.

artículo científico publicado en 2017

Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation

artículo científico publicado en 2009

Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.

artículo científico publicado en 2016

Harnessing the antitumor potential of macrophages for cancer immunotherapy

artículo científico publicado en 2013

Hepatocytes prepare the soil for liver metastasis

scientific article published on 24 June 2019

IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma

artículo científico publicado en 2016

IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.

artículo científico publicado en 2017

Immune escape mechanisms as a guide for cancer immunotherapy

artículo científico publicado en 2015

Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.

artículo científico publicado en 2008

Inflammatory networks cultivate cancer cell metastasis to the liver

artículo científico publicado en 2020

Macrophage-based immunotherapy for the treatment of pancreatic ductal adenocarcinoma

artículo científico publicado en 2013

Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.

artículo científico publicado en 2014

Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal

scientific article published on 21 January 2019

Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer

artículo científico publicado en 2016

Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation

scientific article published on 01 November 2006

Regulation of tumor growth by IFN-gamma in cancer immunotherapy.

artículo científico publicado en 2001

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

artículo científico publicado en 2013

Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance

scientific article published on 01 November 2007

The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance

scientific article published on 09 April 2020

Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.

artículo científico publicado en 2004

Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.

artículo científico publicado en 2016

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

artículo científico publicado en 2012

Lista de obras de Gregory L Beatty

A Pilot Study of Galunisertib Plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma

A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma

Bevacizumab and oxaliplatin-based chemotherapy in metastatic colorectal cancer.

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer

Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists.

Chimeric antigen receptor T cells are vulnerable to immunosuppressive mechanisms present within the tumor microenvironment

Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps

Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers

EMT and dissemination precede pancreatic tumor formation

Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma.

Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages

Expanding Tumor Lymphocytic Infiltration as a Prognostic Tool to Patients with NSCLC Who Are Treated with Radiotherapy?

First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies.

Functio Laesa: Cancer Inflammation and Therapeutic Resistance.

Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation

Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.

Harnessing the antitumor potential of macrophages for cancer immunotherapy

Hepatocytes prepare the soil for liver metastasis

IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma

IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.

Immune escape mechanisms as a guide for cancer immunotherapy

Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.

Inflammatory networks cultivate cancer cell metastasis to the liver

Macrophage-based immunotherapy for the treatment of pancreatic ductal adenocarcinoma

Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies.

Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal

Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer

Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation

Regulation of tumor growth by IFN-gamma in cancer immunotherapy.

T cells expressing chimeric antigen receptors can cause anaphylaxis in humans.

Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance

The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance

Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.

Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.